Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies
出版年份 2021 全文链接
标题
Tuning the efficacy of esterase-activatable prodrug nanoparticles for the treatment of colorectal malignancies
作者
关键词
7-Ethyl-10-hydroxycamptothecin, Prodrug engineering, Nanoparticle delivery, Drug tolerance, Colorectal cancer
出版物
BIOMATERIALS
Volume 270, Issue -, Pages 120705
出版商
Elsevier BV
发表日期
2021-02-05
DOI
10.1016/j.biomaterials.2021.120705
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Modularly Designed Peptide Nanoprodrug Augments Antitumor Immunity of PD-L1 Checkpoint Blockade by Targeting Indoleamine 2,3-Dioxygenase
- (2020) Xuexiang Han et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Fluorescent hollow mesoporous carbon spheres for drug loading and tumor treatment through 980-nm laser and microwave co-irradiation
- (2020) Xin Gui et al. BIOMATERIALS
- Transforming a toxic drug into an efficacious nanomedicine using a lipoprodrug strategy for the treatment of patient-derived melanoma xenografts
- (2020) Linlin Shi et al. JOURNAL OF CONTROLLED RELEASE
- Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures
- (2019) Hongliang He et al. ACCOUNTS OF CHEMICAL RESEARCH
- Novel strategy for oral peptide delivery in incretin-based diabetes treatment
- (2019) Yining Xu et al. GUT
- Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer
- (2019) Ana I. Matos et al. JOURNAL OF CONTROLLED RELEASE
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses
- (2018) Kshipra Singh et al. CANCER RESEARCH
- Structure-Guided Engineering of Cytotoxic Cabazitaxel for an Adaptive Nanoparticle Formulation: Enhancing the Drug Safety and Therapeutic Efficacy
- (2018) Jianqin Wan et al. ADVANCED FUNCTIONAL MATERIALS
- Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study—XELAVIRI (AIO KRK0110)
- (2018) Dominik Paul Modest et al. JOURNAL OF CLINICAL ONCOLOGY
- Revival of a potent therapeutic maytansinoid agent using a strategy that combines covalent drug conjugation with sequential nanoparticle assembly
- (2018) Ke Xie et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Systematic evaluation of graphene quantum dot toxicity to male mouse sexual behaviors, reproductive and offspring health
- (2018) Ding Zhang et al. BIOMATERIALS
- Molecular afterglow imaging with bright, biodegradable polymer nanoparticles
- (2017) Qingqing Miao et al. NATURE BIOTECHNOLOGY
- Highly bioavailable silibinin nanoparticles inhibit HCV infection
- (2016) Ching-Hsuan Liu et al. GUT
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
- (2016) Joseph M. Caster et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
- (2016) Yiming Zhao et al. Nature Communications
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- An Enzyme Cascade Synthesis of ε-Caprolactone and its Oligomers
- (2015) Sandy Schmidt et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- PTH-272 Modulation of NRF2 alters the responsiveness of colorectal cancer cells to irinotecan
- (2015) JP Evans et al. GUT
- Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy
- (2015) Xinpeng Ma et al. JOURNAL OF CONTROLLED RELEASE
- Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer
- (2015) Lin Xie et al. JNCI-Journal of the National Cancer Institute
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt
- (2015) Justin E Wilson et al. NATURE MEDICINE
- Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer
- (2015) Lin Xie et al. JNCI-Journal of the National Cancer Institute
- Structure-Based Rational Design of Prodrugs To Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy
- (2014) Hangxiang Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFN
- (2014) A. Textor et al. CANCER RESEARCH
- Old Drug New Use--Amoxapine and Its Metabolites as Potent Bacterial -Glucuronidase Inhibitors for Alleviating Cancer Drug Toxicity
- (2014) R. Kong et al. CLINICAL CANCER RESEARCH
- The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles
- (2013) Amalina B. Ebrahim Attia et al. BIOMATERIALS
- Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
- (2013) Tomer Cooks et al. CANCER CELL
- Can Controversial Nanotechnology Promise Drug Delivery?
- (2013) Venkat Ratnam Devadasu et al. CHEMICAL REVIEWS
- Cytokines as biomarkers of nanoparticle immunotoxicity
- (2013) Mahmoud Elsabahy et al. CHEMICAL SOCIETY REVIEWS
- Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38
- (2013) Vaskor Bala et al. JOURNAL OF CONTROLLED RELEASE
- Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
- (2012) Sebastien Taurin et al. JOURNAL OF CONTROLLED RELEASE
- Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
- (2011) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Colorectal cancer
- (2010) David Cunningham et al. LANCET
- Cancer Therapies Utilizing the Camptothecins: A Review of thein VivoLiterature
- (2010) Vincent J. Venditto et al. MOLECULAR PHARMACEUTICS
- Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
- (2010) B. D. Wallace et al. SCIENCE
- Synthetic polymeric nanoparticles by nanoprecipitation
- (2009) Stephanie Hornig et al. JOURNAL OF MATERIALS CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started